Puerarin alters the function of monocytes/macrophages and exhibits chondroprotection in mice

Peng,Libo; Xie,Zikang; Pei,Jie; Wang,Bing; Gao,Yi; Qu,Yuxing

doi:10.3892/mmr.2019.9936

Puerarin alters the function of monocytes/macrophages and exhibits chondroprotection in mice

Authors:
- Libo Peng
- Zikang Xie
- Jie Pei
- Bing Wang
- Yi Gao
- Yuxing Qu
View Affiliations

Affiliations: Department of Orthopedics, Changzhou Traditional Chinese Medicine Hospital, Changzhou, Jiangsu 213003, P.R. China
Published online on: February 5, 2019 https://doi.org/10.3892/mmr.2019.9936
Pages: 2876-2882

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Recent studies have suggested that puerarin may impede osteoclastogenesis and facilitate bone regeneration, in addition to attenuating tissue inflammation. The present study investigated the therapeutic effects of puerarin on inflammatory responses and monocyte recruitment in in vitro and in vivo osteoarthritis (OA) models. Puerarin treatment increased the proliferation of OA chondrocytes, as determined by Cell Counting Kit‑8 assay. In addition, the present results suggested that puerarin suppressed the interleukin‑1β‑induced production of inflammatory cytokines in OA chondrocytes and monocytes/macrophages, as assessed by ELISA. In a mouse model of mono‑iodoacetate‑induced OA, the present histological analyses suggested that administration with puerarin attenuated the inflammatory profile of OA joints and reduced cartilage destruction. Using flow cytometry, a decreased number of myeloid‑derived C‑C chemokine receptor 2+/lymphocyte Ag 6C+ monocytes was identified in the blood of OA mice treated with puerarin compared with control OA mice. Furthermore, quantitative real‑time polymerase chain reaction analysis suggested that puerarin treatment decreased C‑C chemokine ligand 2 expression in arthritic tissues. Collectively, the results suggested that puerarin treatment limited the recruitment of inflammatory monocytes. In summary, the present study provided pre‑clinical evidence that puerarin may serve as a potential target in the treatment of OA.

View Figures

View References

1	Poole AR, Rizkalla G, Ionescu M, Reiner A, Brooks E, Rorabeck C, Bourne R and Bogoch E: Osteoarthritis in the human knee: A dynamic process of cartilage matrix degradation, synthesis and reorganization. Agents Actions Suppl. 39:3–13. 1993.PubMed/NCBI
2	Messier SP, Mihalko SL, Legault C, Miller GD, Nicklas BJ, DeVita P, Beavers DP, Hunter DJ, Lyles MF, Eckstein F, et al: Effects of intensive diet and exercise on knee joint loads, inflammation, and clinical outcomes among overweight and obese adults with knee osteoarthritis: The IDEA randomized clinical trial. JAMA. 310:1263–1273. 2013. View Article : Google Scholar : PubMed/NCBI
3	Abramson SB: Inflammation in osteoarthritis. J Rheumatol Suppl. 70:70–76. 2004.PubMed/NCBI
4	Tao J, Cui Y, Duan Y, Zhang N, Wang C and Zhang F: Puerarin attenuates locomotor and cognitive deficits as well as hippocampal neuronal injury through the PI3K/Akt1/GSK-3β signaling pathway in an in vivo model of cerebral ischemia. Oncotarget. 8:106283–106295. 2017. View Article : Google Scholar : PubMed/NCBI
5	Li X, Cai W, Lee K, Liu B, Deng Y, Chen Y, Zhang X, He JC and Zhong Y: Puerarin attenuates diabetic kidney injury through the suppression of NOX4 expression in podocytes. Sci Rep. 7:146032017. View Article : Google Scholar : PubMed/NCBI
6	Zhao J, Cheng Y, Yang C, Lau S, Lao L, Shuai B, Cai J and Rong J: Botanical drug puerarin attenuates 6-hydroxydopamine (6-OHDA)-induced neurotoxicity via upregulating mitochondrial enzyme arginase-2. Mol Neurobiol. 53:2200–2211. 2016. View Article : Google Scholar : PubMed/NCBI
7	Liu B, Zhao C, Li H, Chen X, Ding Y and Xu S: Puerarin protects against heart failure induced by pressure overload through mitigation of ferroptosis. Biochem Biophys Res Commun. 497:233–240. 2018. View Article : Google Scholar : PubMed/NCBI
8	Xu H, Zhao M, Liang S, Huang Q, Xiao Y, Ye L, Wang Q, He L, Ma L, Zhang H, et al: The effects of puerarin on rat ventricular myocytes and the potential mechanism. Sci Rep. 6:354752016. View Article : Google Scholar : PubMed/NCBI
9	Zhang H, Zhai Z, Zhou H, Li Y, Li X, Lin Y, Li W, Shi Y and Zhou MS: Puerarin inhibits oxLDL-induced macrophage activation and foam cell formation in human THP1 macrophage. Biomed Res Int. 2015:4036162015. View Article : Google Scholar : PubMed/NCBI
10	Zhu J, Wang X, Shang Y, Xie X, Zhang F, Chen J and Fu G: Puerarin reduces endothelial progenitor cells senescence through augmentation of telomerase activity. Vascul Pharmacol. 49:106–110. 2008. View Article : Google Scholar : PubMed/NCBI
11	Guo BQ, Xu JB, Xiao M, Ding M and Duan LJ: Puerarin reduces ischemia/reperfusion-induced myocardial injury in diabetic rats via upregulation of vascular endothelial growth factor A/angiotensin-1 and suppression of apoptosis. Mol Med Rep. 17:7421–7427. 2018.PubMed/NCBI
12	Mercer LD, Kelly BL, Horne MK and Beart PM: Dietary polyphenols protect dopamine neurons from oxidative insults and apoptosis: Investigations in primary rat mesencephalic cultures. Biochem Pharmacol. 69:339–345. 2005. View Article : Google Scholar : PubMed/NCBI
13	Kim J, Kim KM, Kim CS, Sohn E, Lee YM, Jo K and Kim JS: Puerarin inhibits the retinal pericyte apoptosis induced by advanced glycation end products in vitro and in vivo by inhibiting NADPH oxidase-related oxidative stress. Free Radic Biol Med. 53:357–365. 2012. View Article : Google Scholar : PubMed/NCBI
14	Fu C, Chen B, Jin X, Liu X, Wang F, Guo R, Chen Z, Zheng H, Wang L and Zhang Y: Puerarin protects endothelial progenitor cells from damage of angiotensin II via activation of ERK1/2Nrf2 signaling pathway. Mol Med Rep. 17:3877–3883. 2018.PubMed/NCBI
15	Deng Y, Lei T, Li H, Mo X, Wang Z and Ou H: ERK5/KLF2 activation is involved in the reducing effects of puerarin on monocyte adhesion to endothelial cells and atherosclerotic lesion in apolipoprotein E-deficient mice. Biochim Biophys Acta Mol Basis Dis. 1864:2590–2599. 2018. View Article : Google Scholar : PubMed/NCBI
16	Lee JH, Jeon YD, Lee YM and Kim DK: The suppressive effect of puerarin on atopic dermatitis-like skin lesions through regulation of inflammatory mediators in vitro and in vivo. Biochem Biophys Res Commun. 498:707–714. 2018. View Article : Google Scholar : PubMed/NCBI
17	Tao Z, Ge Y, Zhou N, Wang Y, Cheng W and Yang Z: Puerarin inhibits cardiac fibrosis via monocyte chemoattractant protein (MCP)-1 and the transforming growth factor-β1 (TGF-β1) pathway in myocardial infarction mice. Am J Transl Res. 8:4425–4433. 2016.PubMed/NCBI
18	Wei HY, Zhang YJ and Zhao SZ: Puerarin regulates neovascular glaucoma through pigment epitheliumderived growth factorinduced NFkappaB signaling pathway. Mol Med Rep. 17:7866–7874. 2018.PubMed/NCBI
19	Liu X, Zhao W, Wang W, Lin S and Yang L: Puerarin suppresses LPS-induced breast cancer cell migration, invasion and adhesion by blockage NF-κB and Erk pathway. Biomed Pharmacother. 92:429–436. 2017. View Article : Google Scholar : PubMed/NCBI
20	Amzaleg Y, Ji J, Kittivanichkul D, E Törnqvist A, Windahl S, Sabag E, Khalid AB, Sternberg H, West M, Katzenellenbogen JA, et al: Estrogens and selective estrogen receptor modulators differentially antagonize Runx2 in ST2 mesenchymal progenitor cells. J Steroid Biochem Mol Biol. 183:10–17. 2018. View Article : Google Scholar : PubMed/NCBI
21	Yuan SY, Sheng T, Liu LQ, Zhang YL, Liu XM, Ma T, Zheng H, Yan Y, Ishimi Y and Wang XX: Puerarin prevents bone loss in ovariectomized mice and inhibits osteoclast formation in vitro. Chin J Nat Med. 14:265–269. 2016.PubMed/NCBI
22	Yang X, Zhang H, Wang J, Zhang Z and Li C: Puerarin decreases bone loss and collagen destruction in rats with ligature-induced periodontitis. J Periodontal Res. 50:748–757. 2015. View Article : Google Scholar : PubMed/NCBI
23	Guingamp C, Gegout-Pottie P, Philippe L, Terlain B, Netter P and Gillet P: Mono-iodoacetate-induced experimental osteoarthritis: A dose-response study of loss of mobility, morphology, and biochemistry. Arthritis Rheum. 40:1670–1679. 1997. View Article : Google Scholar : PubMed/NCBI
24	Ueda MY, Alvarenga PG, Real JM, Moreira Ede S, Watanabe A, Passos-Castilho AM, Vescovi M, Novis Y, Rocha V, Seber A, et al: Optimisation of a quantitative polymerase chain reaction-based strategy for the detection and quantification of human herpesvirus 6 DNA in patients undergoing allogeneic haematopoietic stem cell transplantation. Mem Inst Oswaldo Cruz. 110:461–467. 2015. View Article : Google Scholar : PubMed/NCBI
25	Raghu H, Lepus CM, Wang Q, Wong HH, Lingampalli N, Oliviero F, Punzi L, Giori NJ, Goodman SB, Chu CR, et al: CCL2/CCR2, but not CCL5/CCR5, mediates monocyte recruitment, inflammation and cartilage destruction in osteoarthritis. Ann Rheum Dis. 76:914–922. 2017. View Article : Google Scholar : PubMed/NCBI
26	Yeung DK, Leung SW, Xu YC, Vanhoutte PM and Man RY: Puerarin, an isoflavonoid derived from Radix puerariae, potentiates endothelium-independent relaxation via the cyclic AMP pathway in porcine coronary artery. Eur J Pharmacol. 552:105–111. 2006. View Article : Google Scholar : PubMed/NCBI
27	Zhao J, Luo D, Liang Z, Lao L and Rong J: Plant natural product puerarin ameliorates depressive behaviors and chronic pain in mice with spared nerve injury (SNI). Mol Neurobiol. 54:2801–2812. 2017. View Article : Google Scholar : PubMed/NCBI
28	Wang X, Yan J, Xu X, Duan C, Xie Z, Su Z, Ma H, Ma H, Wei X and Du X: Puerarin prevents LPS-induced acute lung injury via inhibiting inflammatory response. Microb Pathog. 118:170–176. 2018. View Article : Google Scholar : PubMed/NCBI
29	Wu H, Zhao G, Jiang K, Chen X, Zhu Z, Qiu C and Deng G: Puerarin exerts an antiinflammatory effect by inhibiting NF-kB and MAPK activation in staphylococcus aureus-induced mastitis. Phytother Res. 30:1658–1664. 2016. View Article : Google Scholar : PubMed/NCBI
30	Deng HF, Wang S, Li L, Zhou Q, Guo WB, Wang XL, Liu MD, Liu K and Xiao XZ: Puerarin prevents vascular endothelial injury through suppression of NF-κB activation in LPS-challenged human umbilical vein endothelial cells. Biomed Pharmacother. 104:261–267. 2018. View Article : Google Scholar : PubMed/NCBI
31	Tall AR and Yvan-Charvet L: Cholesterol, inflammation and innate immunity. Nat Rev Immunol. 15:104–116. 2015. View Article : Google Scholar : PubMed/NCBI